U.S. Other Utilities Stock News

In the first quarter of 2026, USA TODAY Co., Inc. reported revenue of US$548.49 million, down from US$571.57 million a year earlier, while turning a prior net loss of US$7.33 million into net income of US$19.89 million. The company credited improved profitability to growing digital revenue, AI-related licensing deals, and subscription gains, and reiterated full-year 2026 guidance calling for flat to slightly lower revenue but higher net income compared with last year. Next, we will examine...

Q1 earnings and dividend move draw fresh attention to ConnectOne Bancorp stock ConnectOne Bancorp (CNOB) just reported first quarter results with higher net interest income, net income and earnings per share versus a year ago, alongside an 8.3% increase in its quarterly common dividend. See our latest analysis for ConnectOne Bancorp. At a share price of $30.08, ConnectOne Bancorp has a 30 day share price return of 11.28% and a year to date share price return of 15.16%, alongside a 1 year...

ARK Invest recently acquired over 3 million Intellia Therapeutics shares, worth more than US$43 million. The purchase reflects increased institutional interest in Intellia Therapeutics, which trades under ticker NasdaqGM:NTLA. This transaction follows earlier coverage that focused on Intellia's clinical programs, regulatory updates, and financial position. Intellia Therapeutics focuses on CRISPR/Cas9-based therapeutics, an area that many investors watch closely as gene editing moves from...

Markel Group stock performance snapshot Markel Group (MKL) has seen mixed recent trading, with the stock up roughly 0.8% over the past day but showing declines over the past week, month, past 3 months and year to date. Over the past year, Markel Group reports revenue of US$16.0b and net income of US$1.7b, with its diversified operations spanning specialty insurance, industrial businesses, financial services and various consumer focused subsidiaries. See our latest analysis for Markel...

Soleno Therapeutics stock overview Soleno Therapeutics (SLNO) has drawn investor attention after recent share performance, with the stock showing a one-month return of 34.01% and a three-month return of 25.64%. See our latest analysis for Soleno Therapeutics. That recent momentum sits against a mixed longer record, with a 34.01% 1 month share price return and 25.64% 3 month share price return contrasting with a 28.21% 1 year total shareholder return decline but a very large 3 year total...

If you are wondering whether Conagra Brands at around US$14 still reflects the underlying business, the current share price alone does not tell the full story. The stock has seen a 1.9% decline over the last week, a 10.9% decline over the last month, and is down 19.1% year to date and 34.9% over the last year, which will naturally raise questions about how the market is assessing its risks and potential. These weaker recent returns sit against a longer backdrop, with the stock down 55.6%...

In recent weeks, Goodyear Tire & Rubber has rolled out multiple initiatives, including the launch of its Vector All Season 4 tire, new Eagle performance marketing campaigns, expanded Goodyear Farm Tire-branded product lines, and a 25% USAA member discount, ahead of reporting Q1 2026 results after market close on May 6, 2026. These launches and partnerships highlight Goodyear’s push into premium and specialized segments while using targeted promotions and brand-building to support its broader...

Why the Carlyle partnership matters for SEI Investments (SEIC) The expanded partnership between SEI Investments (SEIC) and Carlyle centers on giving wealth and retirement clients greater access to institutional-style private market strategies, including new model portfolios and defined contribution focused solutions. See our latest analysis for SEI Investments. SEI Investments’ latest share price of $90.79 comes after a 17.89% 1 month share price return and a 9.37% year to date gain, while...

In the first quarter of 2026, Prosperity Bancshares reported net interest income of US$321.15 million and net income of US$116.27 million, while net charge-offs rose to US$41.31 million from US$2.70 million a year earlier. Alongside higher credit costs, the bank continued capital returns through share repurchases and maintained its quarterly dividend, signaling ongoing balance-sheet management priorities. Next, we’ll examine how the surge in net charge-offs and related credit costs may...

GeneDx Holdings (WGS) opened Q1 2026 with recent quarterly revenue of US$120.99 million in Q4 2025 and a basic EPS loss of US$0.61, alongside trailing 12 month revenue of US$427.54 million and a basic EPS loss of US$0.73. Over the last year, revenue has moved from US$95.64 million in Q4 2024 to US$120.99 million in Q4 2025, while quarterly EPS has swung between a profit of US$0.38 in Q2 2025 and losses of up to US$0.61. This sets up an earnings story that investors may review in terms of how...

Veeco Instruments Inc. reported first-quarter 2026 results with sales of US$158.34 million, down from US$167.29 million a year earlier, and swung from an US$11.95 million net profit to a US$0.324 million net loss. At the same time, Veeco announced over US$250 million in new orders for systems used in Indium Phosphide laser manufacturing, underlining growing demand from silicon photonics and hyperscale data centers. We’ll now examine how Veeco’s new US$250 million Indium Phosphide laser...

DiamondRock Hospitality (DRH) is back in focus after first quarter 2026 results topped analyst expectations, with management lifting full year revenue and EBITDA guidance and increasing its emphasis on hotel sales and share repurchases. See our latest analysis for DiamondRock Hospitality. The stock has gained clear momentum around these updates, with a 13.07% 1 month share price return and 16.67% year to date share price return, alongside a 49.70% 1 year total shareholder return. This...

In late April 2026, Builders FirstSource reported first-quarter results showing sales of US$3,287.08 million, a net loss of US$47.41 million, and issued full-year 2026 net sales guidance of US$14.60 billion to US$15.60 billion while launching a new US$500 million share repurchase authorization and continuing to signal interest in acquisitions. Management highlighted an ongoing focus on using free cash flow to fund value-added acquisitions and buybacks even as weaker quarterly performance...

Event context and recent performance snapshot Strive Asset Management (ASST) stock has drawn attention after recent trading, with a 0.9% one day gain, an 8.0% move over the past week, and a 69.3% rise over the past month. See our latest analysis for Strive Asset Management. At a share price of $16.51, Strive Asset Management has a 30-day share price return of 69.33% and a year-to-date share price return of a 4.52% decline, suggesting recent momentum after earlier weakness. If this kind of...

Wondering whether Amprius Technologies at US$21.40 is still worth your attention after a rapid run up, or if the price has already moved ahead of the fundamentals? The stock has returned 8.7% over the last week, 33.8% over the last month, 144.9% year to date, and a very large 1 year return of 822.4%, which puts recent trading firmly on most investors' radar. Recent coverage has focused on Amprius Technologies as interest in battery and electrification related companies has increased, with...

First Bancorp recently reported first-quarter 2026 results, with net interest income rising to US$107.12 million and net income to US$46.66 million, while also disclosing US$1.40 million in net charge-offs for the period. The bank also strengthened its governance and industry expertise by adding alternative-investments specialist Kate Nevin and higher-education leader Peter Hans to its Board of Directors. With earnings growth and expanded board expertise in focus, we’ll now examine how these...

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...

Tronox Holdings plc recently confirmed a quarterly dividend of US$0.0500 per share payable on July 8, 2026, with both the ex-dividend and record dates set in the past on May 11, 2026. Around the same time, Truist downgraded Tronox to Sell, highlighting concerns about cost pressures and near-term earnings guidance despite the dividend affirmation. With Truist’s downgrade foregrounding near-term earnings pressures, we’ll now examine how this development reshapes Tronox’s existing investment...

Heartland Express, Inc. previously reported first-quarter 2026 results showing sales of US$176.26 million versus US$219.42 million a year earlier, with net loss narrowing to US$4.82 million and no share repurchases during the period under its existing buyback programs. Alongside the smaller loss, investors also learned that long-time executive David P. Millis retired as President of Millis Transfer while remaining on Heartland’s board, a leadership shift that may influence how integration...

Supernus Pharmaceuticals (SUPN) is back in focus after reporting first quarter 2026 results that topped Wall Street earnings and revenue expectations, with Qelbree, GOCOVRI, ZURZUVAE, and ONAPGO playing key roles. See our latest analysis for Supernus Pharmaceuticals. Supernus Pharmaceuticals’ share price has been broadly steady in recent months, with a 2.7% 1 month share price decline and a roughly flat 90 day move. However, a 59.0% 1 year total shareholder return points to strong longer term...

Event driven snapshot of Acadia Healthcare Company (ACHC) Acadia Healthcare Company (ACHC) shares have been volatile recently, with a 9% decline over the past week offset by gains of about 5% over the month and roughly 86% in the past 3 months. See our latest analysis for Acadia Healthcare Company. At a share price of $25.27, Acadia Healthcare Company's recent share price return shows sharp short term swings but strong recent momentum, with a 5.47% 30 day gain and 86.49% 90 day gain. This...

If you are wondering whether Keysight Technologies at around US$355.93 is a bargain or already pricing in a lot of optimism, the starting point is to understand what the current valuation is actually implying. The stock has shown strong recent momentum, with returns of 7.1% over 7 days, 22.2% over 30 days, 72.3% year to date, 142.9% over 1 year, 148.9% over 3 years and 156.2% over 5 years. This naturally raises questions about how much upside or risk is now baked into the price. Recent...

CleanSpark (NasdaqCM:CLSK) is accelerating a shift from pure Bitcoin mining toward hosting AI and high performance computing data centers. The company is in advanced talks with a potential investment grade hyperscaler tenant for direct data center capacity. New greenfield AI data center construction is underway in Georgia, backed by CleanSpark’s existing power portfolio. Management is publicly addressing concerns around data center power and water usage as part of this transition. For you...

Amgen (NasdaqGS:AMGN) has been selected by the FDA as one of only two companies to run proof of concept trials under the new real time clinical trials initiative. The program is designed to enable continuous clinical development with real time data sharing between companies and the FDA. The collaboration focuses on reshaping how trials are designed, monitored, and adapted during the development of new therapies. Amgen is a large biotechnology company with a broad portfolio of therapies and...